Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.

J Am Soc Nephrol. 1991 Mar;1(9):1061-80. Unique Identifier : AIDSLINE MED/92003317
Berns JS; Cohen RM; Stumacher RJ; Rudnick MR; Division of Nephrology and Hypertension, Graduate Hospital,; Philadelphia, PA 19146.

Abstract: Patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome are often treated with a variety of potentially nephrotoxic drugs. This review summarizes the renal, fluid, and electrolyte complications of drugs used to treat human immunodeficiency virus and associated opportunistic infections. The pharmacokinetics of the drugs are also briefly reviewed, and dosing guidelines for the use of these drugs in patients who have renal insufficiency or who are receiving dialysis are provided.
Keywords: Anti-Infective Agents/*ADVERSE EFFECTS/PHARMACOKINETICS Antibiotics/ADVERSE EFFECTS Antifungal Agents/ADVERSE EFFECTS Antiprotozoal Agents/ADVERSE EFFECTS Antiviral Agents/ADVERSE EFFECTS Human HIV Infections/COMPLICATIONS/*DRUG THERAPY Kidney/*DRUG EFFECTS Kidney Diseases/CHEMICALLY INDUCED/COMPLICATIONS Opportunistic Infections/COMPLICATIONS/DRUG THERAPY JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC

KWDanti-infectiveagents/KWDadverseeffects/pharmacokineticsantibiotics/adverseeffectsantifungalagents/adverseeffectsantiprotozoalagents/adverseeffectsantiviralagents/adverseeffectshumanhivinfections/complications/KWDdrugtherapykidney/KWDdrugeffectskidneydiseases/chemicallyinduced/complicationsopportunisticinfections/complications/drugtherapyjournalarticlereviewreview,academic
920130
M9210702

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .